Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) just unveiled an update.
ASKA Pharmaceutical Holdings Co., Ltd. announced the cancellation of 1,800,000 treasury shares, representing 5.89% of its issued shares, effective March 21, 2025. This move is part of the company’s strategic financial management, potentially impacting its share value and market perception by reducing the number of outstanding shares, which may benefit shareholders.
More about ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is headquartered in Minato-ku, Tokyo, and is led by President and Representative Director Takashi Yamaguchi.
YTD Price Performance: 7.91%
Average Trading Volume: 52,258
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: Yen64.35B
Find detailed analytics on 4886 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue